| |
KOMISJA NADZORU FINANSOWEGO |
|
| |
|
|
Raport bieżący nr |
2 |
/ |
2022 |
|
|
|
| |
Data sporządzenia: |
2022-03-29 |
|
|
|
|
|
|
|
|
|
| |
Skrócona nazwa emitenta |
|
|
|
|
|
|
|
|
|
| |
MILESTONE MEDICAL |
|
| |
Temat |
|
|
|
|
|
|
|
|
|
|
| |
Commencement of sales of CompuFlo Epidural disposables within two premier pain clinics
in the U.S.
|
|
| |
Podstawa prawna |
|
|
|
|
|
|
|
|
| |
Art. 17 ust. 1 MAR - informacje poufne.
|
|
| |
Treść raportu: |
|
|
|
|
|
|
|
|
|
| |
The Board of Directors of Milestone Medical Inc. _WAR: MMD, "the Company", "the Issuer"_,
today announced that it has commenced sales of the CompuFlo Epidural disposables at
the Cypress Surgery Center in Santa Maria, California and the Galileo Surgery Center
in San Luis Obispo. Both of these prominent premier pain management practices are
located in California and owned by Pain Management Specialists.
Pain Management Specialists _PMS_ is a group of specially trained physicians, dedicated
to the evaluation and treatment of acute and chronic pain. The physicians utilize
the latest techniques and apply the most current theories, to provide patients with
a comprehensive treatment plan, necessary to assist in their fight against pain.
The Board of Directors of the Company continues to expand sales of CompuFlo Epidural
system within pain clinics in the U.S. The selection of the technology by these two
clinics follows successful evaluation of CompuFlo Epidural system as well as the patient
experience.
|
|
|